About Febit
Febit is a Healthcare company based in Wrocław (Poland) founded in 2005, and was acquired by Synthetic Genomics in September 2012. Geniom platform and services are provided for genomic researchers. Its focus areas include Diversified Diagnostics, Life Sciences, Life Sciences Platforms and Tools and Instruments.
Company details
Febit was founded in 2005 and is based in Wroclaw, Poland. Operations focus on the biotechnology sector, where the geniom platform and related services are delivered to support researchers in genomic studies. The Geniom Biochip is offered as a complete, ready-to-use solution for microarray analysis devices, enabling simplified control and execution of genomic research tasks.
- Headquarters Wrocław, Poland
- Stage Acquired
- SectorsHealthcare
- Website febit.com
- Social LinkedIn
- Acquired by Synthetic Genomics (Sep 2012)
- InvestorsSynthetic Genomics
& 1 more
- Acquired bySynthetic Genomics
(Sep 2012)
Funding Insights of Febit
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Febit with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2008 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Febit
Febit has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Synthetic Genomics and In-Q-Tel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm | iqt.org | Washington, Dc, United States | ||
Synthetic genomic solutions are provided for research and bioproduction markets. | 2005 | syntheticgenomics.com | San Diego, United States |
Investor details for Febit
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Febit
3 dated milestones of Febit across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Febit is founded.
- Funding First funding round.
- Exit Acquired by Synthetic Genomics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Febit
Complete news archive for Febit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Febit
Febit was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Febit is headquartered in Wrocław, Poland. It is registered at Wrocław, Lower Silesian Voivodeship, Poland.
Febit was founded in 2005 and is based in Wroclaw, Poland. Operations focus on the biotechnology sector, where the geniom platform and related services are delivered to support researchers in genomic studies. The Geniom Biochip is offered as a complete, ready-to-use solution for microarray analysis devices, enabling simplified control and execution of genomic research tasks.
Febit has 2 investors. Key investors include Synthetic Genomics, and In-Q-Tel.
Yes. Febit was acquired by Synthetic Genomics in September 2012.